Automating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOP

Today's guest is Emmanuel Walckenaer, CEO of YSEOP. A firm based in Paris, YSEOP focuses on natural language generation across financial services and life sciences industries. Emmanuel speaks with us this week about the applications of NLG when it comes to drug discovery and life sciences. Emmanuel also discusses some other life sciences and AI trends that he thinks are promising and some of the trends that he's seen in his work in the life sciences space. This episode is sponsored by YSEOP. If you're interested in reaching the Emerj audience, you have an important educational message about use-cases and applications of AI, be sure to contact us at emerj.com/ad1.